Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CHU Dual-Energy Ablation in Ventricular Arrhythmia

NCT: NCT07503769 · ENROLLING_BY_INVITATION

NCT IDNCT07503769
StatusENROLLING_BY_INVITATION
Start Date2026-02-03
Completion2026-10-31

Brief Summary

The objective of this study is to evaluate the safety of the dual-energy ablation catheter manufactured by Shanghai MicroPort EP Medical Technology Co., Ltd. in the treatment of tachyarrhythmias.

Frequently Asked Questions

What is CHU Dual-Energy Ablation in Ventricular Arrhythmia?

CHU Dual-Energy Ablation in Ventricular Arrhythmia is a clinical trial registered under NCT07503769. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07503769?

The current status of NCT07503769 (CHU Dual-Energy Ablation in Ventricular Arrhythmia) is: ENROLLING_BY_INVITATION.

When did CHU Dual-Energy Ablation in Ventricular Arrhythmia start?

CHU Dual-Energy Ablation in Ventricular Arrhythmia started on 2026-02-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.